 |
|
OTC statins: a bad decision for public health (p 1659)
May 19, 2004This week's editorial raises concerns over the recent decision by the UK government to make the cholesterol-lowering drug simvastatin available over the counter (OTC) from July this year for people at moderate risk of cardiovascular disease.
The editorial comments: 'There are no trials of OTC statins for primary prevention of heart disease. There are no data on compliance with OTC statins, which for products that need to be taken daily longterm is a concern. Will those who buy simvastatin also stop smoking, lose weight, and do more exercise, or will they substitute drug use for lifestyle modification? Will pharmacists have the time to determine the individual's risk of coronary heart disease before selling the drug and also to give lifestyle advice? All these are unknowns, which is unfortunate for the UK public, who will be the guineapigs in this large-scale OTC experiment. Americans have escaped this role, with two applications for OTC statins (pravastatin 10 mg and lovastatin 10 mg) being rejected in 2000 because of insufficient evidence that either drug could be used safely and effectively in an OTC setting'.
Financial reasons are suggested as the driver behind the decision: 'In the absence of evidence of the overall mortality benefits of OTC simvastatin, it is difficult to avoid concluding that the motive behind the Government's decision is saving money. Statins are currently prescribed to about 1"˘8 million people in the UK, costing the NHS £700 million a year. With the NHS bill for statins predicted to be more than £2 billion a year by 2010, transferring costs to patients might seem timely. But privatising the prevention of heart disease will increase inequalities, with many unable to afford the likely £10-15 per month longterm. For the manufacturer, of course, the motive is clear. With simvastatin now off patent, creation of a new market (perhaps 8 million more people in the UK) will please shareholders'.
The editorial concludes: 'What is now needed is a surveillance system for OTC simvastatin. Evidence of benefit and risk must be collated in this primary-prevention setting, and used to decide on applications for increased doses of simvastatin or other statins to be available OTC. In the meantime the planned National Institute for Clinical Excellence appraisal of statins for prevention of coronary events due to be published in June, 2005, should be fast-tracked to provide updated guidance on statin prescribing. If the Government is serious about preventing heart disease, then privatisation of that prevention is not the answer. And if the UK public is to be used in an OTC experiment, then the evidence must be collected and used for the benefit of all.'
Lancet
Heart Disease Current Events and Heart Disease News RSSTraditional Risk Assessment Tools Do Not Accurately Predict Coronary Heart Disease
The Framingham and National Cholesterol Education Program tools, NCEP, do not accurately predict coronary heart disease, according to a study performed at the Yale University School of Medicine in New Haven, CT.
Researchers engineer pancreatic cell transplants to evade immune response
In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients.
Safe new therapy for genetic heart disease
A new clinical trial suggests that long-term use of candesartan, a drug currently used to treat hypertension, may significantly reduce the symptoms of genetic heart disease.
Simple Model Predicts Those at Risk for Chronic Kidney Disease
Traditionally, doctors have had no clear way to predict which of their patients might be headed down the road to chronic kidney disease (CKD).
Eating at buffets plus not exercising equals obesity in rural America
In small towns in the Midwestern United States, people who eat out often at buffets and cafeterias and who perceive their community to be unpleasant for physical activity are more likely to be obese.
Researchers compile 'molecular manual' for 100s of inherited diseases
An international research team has compiled the first catalogue of tissue-specific pathologies underlying hundreds of inherited diseases.
Patients with severe psoriasis need evaluation of heart disease risk
According to new recommendations in the December 10 issue of The American Journal of Cardiology (AJC), published by Elsevier, new research is called for and patients with severe forms of the skin disease psoriasis should receive evaluation and possible treatment to reduce their risk of coronary artery disease (CAD).
Rare disease provides clues about enzyme role in arrhythmias
A University of Iowa study provides insight into a calcium-sensing enzyme already known to play a role in irregular heartbeats and other critical functions.
Cellular 'brakes' may slow memory process in aging brains
University of Florida researchers may have discovered why some brain cells necessary for healthy memory can survive old age or disease, while similar cells hardly a hairsbreadth away die.
Gene therapy effective treatment against gum disease
Scientists at the University of Michigan have shown that gene therapy can be used to successfully stop the development of periodontal disease, the leading cause of tooth loss in adults.
More Heart Disease Current Events and Heart Disease News Articles
 | Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty (PATHOPHYSIOLOGY OF HEART DISEASE (LILLY)) Completely rewritten and updated for its Fourth Edition, this best-selling text is a comprehensive, clear, concise, and easy-to-understand introduction to cardiovascular diseases. It is written by internationally recognized Harvard Medical School faculty and select medical students, and is the best text to bridge basic physiology with clinical care of patients. This edition provides updated... |
 | NO More Heart Disease: How Nitric Oxide Can Prevent--Even Reverse--Heart Disease and Strokes by Louis Ignarro Dr. Louis Ignarro discovered "the atom" of cardiovascular health--a tiny molecule called Nitric Oxide. NO, as it is known by chemists, is a signaling molecule produced by the body, and is a vasodilator that helps control blood flow to every part of the body. Dr. Ignarro's findings led to the development of Viagra. Nitric Oxide has a beneficial effect on the cardiovascular system as well.NO... |
 | Prevent and Reverse Heart Disease: The Revolutionary, Scientifically Proven, Nutrition-Based Cure by Caldwell B. Esselstyn A powerful call for a paradigm shift in heart disease therapy. Based on the groundbreaking results of a twenty-year nutritional study by Dr. Esselstyn, a preeminent researcher and clinician, this book illustrates that a plant-based, oil-free diet can not only prevent and stop the progression of heart disease but can also reverse its effects. The proof lies in the incredible outcomes for patients... |
 | Reverse Heart Disease Now: Stop Deadly Cardiovascular Plaque Before It's Too Late by Sinatra, James C., M.D. Roberts While most books focus solely on the role of cholesterol in heart disease, Reverse Heart Disease Now draws on new research that points to the surprising other causes. Two leading cardiologists draw on their collective fifty years of clinical cardiology research to show you how to combine the benefits of modern medicine, over-the-counter vitamins and supplements, and simple lifestyle changes to... |
 | Dr. Dean Ornish's Program for Reversing Heart Disease by Dr Dean Ornish Dr. Dean Ornish was the first person to offer scientific proof that heart disease often can be halted or even reversed simply by changing your diet and lifestyle. Based on his internationally acclaimed scientific studies, Dr. Ornish's program yielded amazing results. Participants often reduced or discontinued medications; their chest pains usually diminished or disappeared; they felt more... |
 | Reversing Heart Disease: A Vital New Program to Help Prevent, Treat, and Eliminate Cardiac Problems Without Surgery by Julian M. Whitaker Here is an update of the complete guide to cardiac carepacked with new ways to conquer heart disease without drugs or bypass surgery! Hundreds of thousands of heart patients have used Dr. Julian Whitakers best-selling Reversing Heart Disease to successfully deal with cardiac problems naturally. Now, drawing on nearly 20 years of experience at his Whitaker Wellness Institute, Dr. Whitaker examines... |
 | Moss and Adams' Heart Disease in Infants, Children and Adolescents: Including the Fetus and Young Adult, 2 Volume Set Established since 1968 as a classic pediatric cardiology text, this two-volume work is now in its Seventh Edition. Leading international experts describe state-of-the-art diagnostic and interventional techniques for young patients with congenital and acquired heart diseases and for adult survivors of congenital heart disease. This edition's section on pediatric cardiac intensive care has new... |
 | The No Bull Book on Heart Disease: Real Answers to Winning Back Your Heart and Health by Joel Okner, Jeremy Clorfene Written in plain English by a board-certified cardiologist and a clinical psychologist who specializes in heart disease, this is a practical “what-to-expect” guide that will help readers cope with their confusion, fear, and lack of information, as well as decode what doctors really mean when they describe certain cardiac procedures, treatments, and medications. The authors clearly explain... |
| Dr. Dean Ornish's Program for Reversing Heart Disease by Dr. Dean Ornish | |
 | Congenital Heart Disease in Adults (Congenital Heart Disease in Adults (Perloff/Child)) by Joseph K. Perloff, John S. Child, Jamil Aboulhosn Dr. Perloff, the founding father of the field of adult congenital heart disease, presents a decade's worth of research and clinical data in the completely redefined 3rd edition to bring you the most current information. With advances in diagnosis and treatment in children, more and more of those with CHD survive well into adulthood. Expert contributors in various fields offer a... |
| © 2009 BrightSurf.com |